Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
Background/Aims: The endocannabinoid signalling (ECS) system has been known to regulate glucose homeostasis. Previous studies have suggested that the cannabinoid 2 (CB2) receptor may play a regulatory role on insulin secretion, immune modulation and insulin resistance. Given that diabetes and insuli...
Main Authors: | Xiuyuan Zhang, Shan Gao, Jinfeng Niu, Pan Li, Juan Deng, Shixin Xu, Zhihong Wang, Weiwei Wang, Deling Kong, Chen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/453171 |
Similar Items
Similar Items
-
In vitro effects of endogenous and exogenous cannabinoids on insulin resistance and secretion
by: Gallant, Megan
Published: (2009) -
Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance
by: Oktay Kaya, et al.
Published: (2019-01-01) -
Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion
by: Laura L. Murphy, et al.
Published: (1998-12-01) -
The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice
by: Francisco J. Bermudez-Silva, et al.
Published: (2016-01-01) -
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
by: Arulkumar Nagappan, et al.
Published: (2019-04-01)